Trial Profile
A Short-term Single-arm Study to Evaluate the Efficacy and Safety of Add-on Canagliflozin when Administered in Combination with A Half Dose of Preceding Sulfonylurea (SU) in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 15 Mar 2016 New trial record